Accessibility Menu
Establishment Labs logo

Establishment Labs

(NASDAQ) ESTA

Current Price$91.69
Market Cap$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2018)+273%
5 Year+23%
1 Year+111%
1 Month+12%
Establishment Labs last closing stock price
MetricPriceDate
Last closeUSD 92.302026-07-16
Establishment Labs stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.98%USD 88.772026-07-09
1 month+11.78%USD 82.572026-06-16
3 month+37.6%USD 67.082026-04-17
Year to date+26.65%USD 72.882025-12-31
1 year+111.41%USD 43.662025-07-16
3 year+29.65%USD 71.192023-07-17
5 year+23.4%USD 74.802021-07-16
Since inception+272.93%USD 24.752018-07-19

Establishment Labs Financials at a Glance

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$229.58M

Net Income (TTM)

-$43.74M

EPS (TTM)

-$1.48

P/E Ratio

-62.16

Dividend

$0.00

Beta (Volatility)

1.67 (High)

Price

$91.69

Volume

3,391

Open

$91.35

Previous Close

$92.30

Daily Range

$90.58 - $92.55

52-Week Range

$33.35 - $93.12

Estimated Earnings Date

Aug 6, 2026

ESTA News

SellAlert-Blue.png

A Hedge Fund Dumped Establishment Labs Shares Worth $6.6 Million. Here's a Closer Look at the Transaction.

Robert IzquierdoJul 5, 2026
SellAlert-Red.png

Wealth Manager Sells $7 Million of Establishment Labs After Massive Gains. Is This Medical Device Stock a Buy?

Kris EddyMay 30, 2026
SellAlert-Purple.png

ESTA Founder Sells $7.9M on Earnings Day — Here's Why that's Not the Story

Seena HassounaMay 11, 2026
SellAlert-Green.png

Establishment Labs Insider Sells 37,500 Shares as Stock Jumps 128% in a Year

Jonathan PoncianoApr 21, 2026
Stock chart down - person covering face

Why Establishment Labs Stock Is Crashing Today

Keith SpeightsNov 8, 2023

ESTA: Motley Fool Moneyball Superscore

73

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Establishment Labs

Establishment Labs makes medical tools for breast surgery patients. These products help people during aesthetic and reconstructive procedures. Doctors use these silicone implants to improve surgery outcomes.

A Smarter Surgical Tool

  • Motiva Implants: Silicone gel-filled breast implants used in surgeries; represented substantially all revenue in the first quarter of 2026.
  • Ergonomix Series: Gravity-sensitive silicone breast implants designed to mimic the movement of natural human tissue.
  • Flora Tissue Expander: Medical device used to stretch skin for reconstruction; approved by the U.S. Food and Drug Administration in 2023.
  • Puregraft Tools: Specialized systems used for collecting and redistributing a patient's own fat tissue during plastic surgery.

Growing the Global Footprint

  • Received approval from the U.S. Food and Drug Administration in October 2024 to sell Motiva Implants in the United States.
  • Acquired Motiva Benelux BV and Motiva NL BV in October 2024 to grow its direct sales force in Europe.
  • Finished construction of a new manufacturing facility in Costa Rica in 2024 to increase global production capacity.
  • Amended its debt agreement with Oaktree Fund Administration in April 2026 to access up to $300 million in loans.

What Sets the Tech Apart

The company uses specialized surface technology designed to lower patient health risks and improve healing. It also benefits from a specific tax status in Costa Rica that helps reduce its overall business expenses.

Tracking the Latest Numbers

  • Total revenue reached $59.9 million in the first quarter of 2026, up 44.7% from $41.4 million in the first quarter of 2025.
  • Gross profit was $42.3 million in the first quarter of 2026, a 52.2% increase over the previous year.
  • Net loss narrowed to $13.4 million in the first quarter of 2026, an improvement from $20.7 million in the same period last year.
  • United States sales reached 32.7% of total revenue in the first quarter of 2026, up from 15.5% in the first quarter of 2025.

The Bottom Line

Establishment Labs has evolved from an international startup into a global manufacturer with a major presence in the United States market. Its focus on innovative safety features and direct distribution has helped improve its financial results while expanding its reach.

AI Generated • May 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

1,004

CEO

Peter Caldini, MBA

Website

www.establishmentlabs.com

Headquarters

Austin, TX 78758, US

ESTA Financials

Key Financial Metrics (TTM)

Gross Margin

70.06%

Operating Margin

-12.45%

Net Income Margin

-19.05%

Return on Equity

-225.86%

Return on Capital

-13.54%

Return on Assets

-12.46%

Earnings Yield

-1.61%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

29.43M

Volume

3.39K

Avg. Volume

606.18K

Financials (TTM)

Gross Profit

$160.84M

Operating Income

-$28.57M

EBITDA

-$14.38M

Operating Cash Flow

-$34.81M

Capital Expenditure

-$7.41M

Free Cash Flow

-$42.23M

Cash & ST Invst.

$68.10M

Total Debt

$263.96M

Establishment Labs Performance Analysis

Establishment Labs annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 161,700,00027.6%
20232023-12-31USD 165,151,0002.1%
20242024-12-31USD 166,025,0000.5%
20252025-12-31USD 211,076,00027.1%
Establishment Labs sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3024.0%
Q32025-09-304.8%
Q42025-12-3120.1%
Q12026-03-31-7.3%
Establishment Labs annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3.0879.2%
20232023-12-31USD -3.07-0.3%
20242024-12-31USD -3.00-2.0%
20252025-12-31USD -1.72-42.6%
Establishment Labs sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-06-3020.0%
Q32025-09-3032.1%
Q42025-12-3176.8%
Q12026-03-31-409.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$59.88M

+44.7%

Gross Profit

$42.34M

+52.2%

Gross Margin

70.70%

N/A

Market Cap

$2.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$2.71M

N/A

Employees

1,004

N/A

Net Income

-$13.38M

+35.4%

EBITDA

-$3.31M

+70.9%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$68.10M

-1.6%

Total Debt

$263.96M

+16.9%

Accounts Receivable

$77.08M

+21.9%

Inventory

$87.06M

-3.7%

Long Term Debt

$251.00M

+12.0%

Short Term Debt

$12.96M

+731.7%

Return on Assets

-12.46%

N/A

Return on Invested Capital

-10.67%

N/A

Free Cash Flow

-$6.27M

+70.8%

Operating Cash Flow

-$4.31M

+79.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
UFPTUFP Technologies, Inc.
$243.62-5.11%
NVCRNovocure Ltd
$16.13-1.77%
ZYMEZymeworks Inc.
$24.30+0.43%
TDOCTeladoc Health, Inc.
$9.38-1.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$6.70+0.01%
AALAmerican Airlines Group
$15.14-0.03%
NOKNokia
$10.31-0.01%
TQQQProShares Trust - ProShares UltraPro Qqq
$69.03-0.02%

Questions About ESTA

What is the current price of Establishment Labs?

Establishment Labs is trading at $91.69 per share.

What is the 52-week range for Establishment Labs?

Over the past 52 weeks, Establishment Labs has traded between $33.35 and $93.12.

How much debt does Establishment Labs have?

As of the most recent reporting period, Establishment Labs reported total debt of $263.96M.

How much cash does Establishment Labs have on hand?

Establishment Labs reported $68.10M in cash and cash equivalents in its most recent financial results.

What is Establishment Labs’s dividend yield?

Establishment Labs does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services